Results

Total Results: 2,080 records

Showing results for "drug".

141. Topic Brief: Updating Treatments for Fecal Incontinence (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_10.pdf
     October 26, 2020 - 2020 1 ((anal or fecal or faecal) adj incontinen*).ti. (584) 2 (biofeedback or device* or diet* or drug … 2020 1 ((anal or fecal or faecal) adj incontinen*).ti. (15) 2 (biofeedback or device* or diet* or drug … incontinence OR fecal incontinence OR faecal incontinence ) AND ( biofeedback OR device OR diet OR drug … Does the nomination represent a health care drug, intervention, device, technology, or health care … Abbreviations: CCFIS = Cleveland clinical fecal incontinence score; FDA = food and drug administration

142. Topic Brief: Updating Treatments for Fecal Incontinence (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_9.pdf
     October 26, 2020 - 2020 1 ((anal or fecal or faecal) adj incontinen*).ti. (584) 2 (biofeedback or device* or diet* or drug … 2020 1 ((anal or fecal or faecal) adj incontinen*).ti. (15) 2 (biofeedback or device* or diet* or drug … incontinence OR fecal incontinence OR faecal incontinence ) AND ( biofeedback OR device OR diet OR drug … Does the nomination represent a health care drug, intervention, device, technology, or health care … Abbreviations: CCFIS = Cleveland clinical fecal incontinence score; FDA = food and drug administration

143. Topic Brief: Updating Treatments for Fecal Incontinence (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_8.pdf
     October 26, 2020 - 2020 1 ((anal or fecal or faecal) adj incontinen*).ti. (584) 2 (biofeedback or device* or diet* or drug … 2020 1 ((anal or fecal or faecal) adj incontinen*).ti. (15) 2 (biofeedback or device* or diet* or drug … incontinence OR fecal incontinence OR faecal incontinence ) AND ( biofeedback OR device OR diet OR drug … Does the nomination represent a health care drug, intervention, device, technology, or health care … Abbreviations: CCFIS = Cleveland clinical fecal incontinence score; FDA = food and drug administration

144. Topic Brief: Updating Treatments for Fecal Incontinence (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_7.pdf
     October 26, 2020 - 2020 1 ((anal or fecal or faecal) adj incontinen*).ti. (584) 2 (biofeedback or device* or diet* or drug … 2020 1 ((anal or fecal or faecal) adj incontinen*).ti. (15) 2 (biofeedback or device* or diet* or drug … incontinence OR fecal incontinence OR faecal incontinence ) AND ( biofeedback OR device OR diet OR drug … Does the nomination represent a health care drug, intervention, device, technology, or health care … Abbreviations: CCFIS = Cleveland clinical fecal incontinence score; FDA = food and drug administration

145. Topic Brief: Updating Treatments for Fecal Incontinence (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_5.pdf
     October 26, 2020 - 2020 1 ((anal or fecal or faecal) adj incontinen*).ti. (584) 2 (biofeedback or device* or diet* or drug … 2020 1 ((anal or fecal or faecal) adj incontinen*).ti. (15) 2 (biofeedback or device* or diet* or drug … incontinence OR fecal incontinence OR faecal incontinence ) AND ( biofeedback OR device OR diet OR drug … Does the nomination represent a health care drug, intervention, device, technology, or health care … Abbreviations: CCFIS = Cleveland clinical fecal incontinence score; FDA = food and drug administration

146. Topic Brief: Updating Treatments for Fecal Incontinence (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_6.pdf
     October 26, 2020 - 2020 1 ((anal or fecal or faecal) adj incontinen*).ti. (584) 2 (biofeedback or device* or diet* or drug … 2020 1 ((anal or fecal or faecal) adj incontinen*).ti. (15) 2 (biofeedback or device* or diet* or drug … incontinence OR fecal incontinence OR faecal incontinence ) AND ( biofeedback OR device OR diet OR drug … Does the nomination represent a health care drug, intervention, device, technology, or health care … Abbreviations: CCFIS = Cleveland clinical fecal incontinence score; FDA = food and drug administration

147. Topic Brief: Updating Treatments for Fecal Incontinence (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_4.pdf
     October 26, 2020 - 2020 1 ((anal or fecal or faecal) adj incontinen*).ti. (584) 2 (biofeedback or device* or diet* or drug … 2020 1 ((anal or fecal or faecal) adj incontinen*).ti. (15) 2 (biofeedback or device* or diet* or drug … incontinence OR fecal incontinence OR faecal incontinence ) AND ( biofeedback OR device OR diet OR drug … Does the nomination represent a health care drug, intervention, device, technology, or health care … Abbreviations: CCFIS = Cleveland clinical fecal incontinence score; FDA = food and drug administration

148. Topic Brief: Updating Treatments for Fecal Incontinence (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_3.pdf
     October 26, 2020 - 2020 1 ((anal or fecal or faecal) adj incontinen*).ti. (584) 2 (biofeedback or device* or diet* or drug … 2020 1 ((anal or fecal or faecal) adj incontinen*).ti. (15) 2 (biofeedback or device* or diet* or drug … incontinence OR fecal incontinence OR faecal incontinence ) AND ( biofeedback OR device OR diet OR drug … Does the nomination represent a health care drug, intervention, device, technology, or health care … Abbreviations: CCFIS = Cleveland clinical fecal incontinence score; FDA = food and drug administration

149. Medicare-Medication-Use Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-medication-use_research.pdf
     April 01, 2014 - Drugs are consolidated into 95 drug groups, and drug groups are consolidated into 18 drug categories … and drug group use and catastrophic coverage use. … The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug … Costs for Medicare drug coverage: yearly deductible for drug plans. … categories and groups Drug category Drug group Drug category Drug group Drug category Drug group ADHD

150. Comparative Effectiveness of Preventive Pharmacological Treatments for Migraine | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/migraine-prevention/research-protocol
     November 03, 2011 - Food and Drug Administration (FDA) for migraine prevention in adults come from different drug classes … surveillance, or interactive drug monitoring. … , patient education, drug surveillance, or interactive drug monitoring) influence results? … , patient education, drug surveillance, or interactive drug monitoring) influence results? … Pharmacological classes for migraine prevention Drug, ATC Code* Class of Drug ANTIEPILEPTICS

151. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substanceabuse_hi_impact.pdf
     January 01, 2012 - Food and Drug Administration (FDA) in October 2011 about preparing its new drug application and the … National Institute on Drug Abuse (NIDA). Prescription drugs: abuse and addiction. [internet]. … Food and Drug Administration. [internet]. … Food and Drug Administration. [internet]. … [internet]. drug- rehabs.com; [accessed 2011 Jan 5]. [3 p].

152. Ch 5-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_5-user-guide-to-ocer_130129.pdf
     January 01, 2012 - Therefore, selection of a comparator of the same treatment modality (e.g., drug vs. drug) and same … However, in a CER comparing the effects of drug A versus drug B, misclassification of exposure A would … A lower-dose comparison drug may make the study drug look more effective, 66 Developing an Observational … CER Protocol: A User’s Guide while a higher-dose comparison drug may make the study drug look safer … Pharmacoepidemiol Drug Saf. 2012;21 Suppl 2:81-9. 16. Maldonado G, Greenland S.

153. Evidence Summary CER 208 Treatment For Bipolar Disorder In Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-evidence-summary.pdf
     August 01, 2018 - their lifetime.6 Of all psychiatric conditions, BD is the most likely to co-occur with alcohol or drug … abuse disorders.7 Purpose of Review To assess the effectiveness of drug and nondrug therapies for … Drug treatments have several purposes. … The publications comprised 67 unique drug studies for acute mania, seven drug studies for depression … We found scattered evidence for some drug interventions that were assessed 3 Table A.

154. Communicating Harms and Benefits of Prescription Drugs to Healthcare Consumers (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_hickam.ppt
     December 01, 2006 - practice & research Morning Presentations Innovative Methods of Communicating Harms and Benefits of Drug

155. Comparative Effectiveness of Drug Therapy for Psoriatic Arthritis in Adults – An Update to the 2007 Report | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/arthritis-psoriatric/research-protocol
     December 06, 2010 - Review Aug. 17, 2012 Topic Initiated Jul. 3, 2013 Surveillance Report Comparative Effectiveness of Drug … Food and Drug Administration (FDA) to treat patients with PsA are adalimumab, etanercept, golimumab, … The first review did not include certolizumab pegol, golimumab, and tocilizumab drug therapies listed … KQ3: For patients with psoriatic arthritis, do drug therapies differ in harms, tolerability, adherence … KQ4: What are the comparative benefits and harms of drug therapies for psoriatic arthritis in subgroups

156. Nonopioid Pharmacologic Treatments for Chronic Pain | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/nonopioid-chronic-pain/protocol
     March 01, 2019 - Specific adverse events for each drug class, such as gastrointestinal events, cardiovascular events, … sedation for gabapentin/pregabalin Intermediate outcomes (e.g., pharmacokinetics/pharmacodynamics, drug-drug … Pharmacoepidemiol Drug Saf. 2009;18(12):1166-75. doi: 10.1002/pds.1833. … Pharmacoepidemiology and drug safety. 2009;18(12):1166-75. Higgins J, Green S. … Methods for the Drug Effectiveness Review Project.

157. Nonopioid Pharmacologic Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonopioid-pharm-chronic-pain-protocol.pdf
     February 01, 2019 - Specific adverse events for each drug class, such as gastrointestinal events, cardiovascular events, … sedation for gabapentin/pregabalin • Intermediate outcomes (e.g., pharmacokinetics/pharmacodynamics, drug-drug … Pharmacoepidemiol Drug Saf. 2009;18(12):1166-75. doi: 10.1002/pds.1833. PMID: 19718704 7. … Pharmacoepidemiology and drug safety. 2009;18(12):1166-75. 15. Higgins J, Green S. … Methods for the Drug Effectiveness Review Project.

158. A Rapid Evidence Review of Retention Strategies for Medications for Addiction Treatment (MAT) in Adults with Opioid Use Disorder | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/retention-strategies-opioid-use-disorder/rapid-protocol
     May 08, 2019 - Food and Drug Administration approved medications for OUD- methadone, buprenorphine, and extended-release … This rapid review, nominated by the Office of the Assistant Secretary for Health (OASH), Center for Drug … Food and Drug Administration (FDA), the Office of the Assistant Secretary for Mental Health and Substance … the Office of the Assistant Secretary for Planning and Evaluation (ASPE), the National Institute on Drug … Drug and Opioid-Involved Overdose Deaths - United States, 2013- 2017 .

159. Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_1.pdf
     April 01, 2020 - cognitive impairment; biomarker accuracy for Alzheimer’s disease (AD) in dementia; and effects of CATD drug … Few trials directly compared different drug treatments. … Future BPSD trials also should directly compare drug and nondrug treatment strategies, and drug trials … Food & Drug Administration. U.S. … Food & Drug Administration.

160. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_2012-12-11.pdf
     January 01, 2012 - The drug is classified by the U.S. … Drug Enforcement Administration (DEA) as a Schedule IV drug, which means DEA will review FDA’s recommendation … This drug combination acts on the central nervous system as an appetite suppressant. … FDA approved the drug on July 17, 2012, on the basis of two completed, phase III trials. … Food and Drug Administration (FDA).